The newsletter doesn't display correctly?
View it in the browser
red square   Technology
Transfer Office
  TTO Newsletter


Word from the team


Dear reader,

Looking for a good read before the Christmas break? Interested in licensing opportunities for 2024? Here are some success stories from the EPFL ecosystem highlighted by the TTO in the last quarter. Let yourself be inspired and start dreaming about your future business!

Happy Holidays,

The TTO Team


The EPFL start-up TreaTech gets 9 more millions to continue revolutionising waste disposal



Technology transfer in action


“Revolutionising waste disposal by harnessing the power of the circular economy”. With this bold claim, the EPFL spin-off TreaTech sets a high bar. And is ready to deliver: the Lausanne-based start-up has announced the closing of a successful Series A financing for CHF 9 million this summer. The young cleantech company can turn your liquid waste to gold. Literally. Here is how.

Read the article




Featured news

  • GliaPharm secures $4.2 million to advance its lead program
    The Alzheimer’s Drug Discovery Foundation has invested $4.2M to accelerate the development of GliaPharm’s lead compound through investigational new drug-enabling studies to gain approval for clinical testing in Alzheimer’s disease.
  • Vandria raises USD 20.6M and emerges from stealth
    Vandria was spun out of Amazentis SA, an EPFL start-up, in 2021 with backing from ND Capital to develop first-in-class small molecule mitophagy inducers against a novel target to rejuvenate cells and treat age-related and chronic diseases. Its lead program is on track to enter clinical trials in Europe in Q2 2024.
  • Sustainable Building Tech Startup Vizcab Raises $5.5 Million
    Sustainable building design software provider Vizcab announced today that it has raised $5.5 million in a Series A funding round, aimed at supporting the acceleration of net zero in the construction industry.
  • Parkinson's disease: a neuroprosthetic to correct walking disorders
    Neuroscientists and neurosurgeons at the EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthetic intended to correct walking disorders associated with Parkinson’s disease.
  • Nu Glass lands major Swiss Railway order
    The EPFL spin-off just won a major contract with the Swiss Railway Company (CFF-SBB) to apply its laser treatment to 5700 glasses of 40 InterCity trains to improve mobile connectivity. More orders should follow soon as the solution is raising interest in Switzerland and abroad.
  • Swiss startups in the spotlight: a global media perspective
    Switzerland has been a global leader in innovation for decades, thanks to its thriving startup ecosystem. This press review showcases some of the best articles that highlight the Swiss startup excellence.



Latest licensing opportunities


 Innovation Events


Sustainability Leaders

Think Tank #21: 11.01.2024


Startup Board Academy

Online: Jan 2024


Monthly Afterwork

@ puur: 18.01.2024


Find more EPFL Innovation Park events


Get in touch?


Follow us